17th Sep 2021 17:50
MaxCyte Inc - Maryland, US-based biotechnology company - Is set to join the Russell 3000 and Russell 2000 indices, which will take effect when US markets open on Monday next week.
"The addition of MaxCyte to the Russell indices highlights our strong financial profile and marks a milestone in our progress towards being the premier cell engineering platform technology. Our inclusion follows the successful closing of our Nasdaq IPO in August and elevates the overall awareness of our stock amongst the investment community," says Chief Executive Officer Doug Doerfler.
Current stock price: 1,070.00 pence
Year-to-date change: more than double
By Dayo Laniyan; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
MaxCyte